CCR2 and neoplasm: We therefore suggest a multi-step model in which CCR2+ CD11b+ BM cells accumulate at the tumor site to initially support tumor development and angiogenesis, resulting in enhanced levels of various inflammatory cytokines, growth factors and chemokines, that enable the rapid attraction of other BM cells, including those that are CCR2−, to further assist tumor development and progression.